LC-MS of novel narcoepileptics and related substances

Journal of Separation Science

Volumn 32, Issue 9, 2009, Pages 1312-1322

  Rao, Ramisetti Nageswara ^a   Shinde, Dhananjay D ^a   Ramesh, Venna ^a   Srinivas, Ragampeta ^a  

^a INDIAN INSTITUTE OF CHEMICAL TECHNOLOGY   (India)

Author keywords

Adrafinil; LC MS; Modafinil; MS; Narcolepsy; Psychostimulants

Indexed keywords

ADRAFINIL; LC-MS; MODAFINIL; MS; NARCOLEPSY; PSYCHOSTIMULANTS;

QUALITY ASSURANCE; TOTAL QUALITY MANAGEMENT;

AMMONIUM COMPOUNDS;

ADRAFINIL; AMMONIUM ACETATE; MODAFINIL; SULFONE DERIVATIVE; SULFOXIDE;

ARTICLE; DRUG IMPURITY; DRUG PURITY; DRUG STRUCTURE; DRUG SYNTHESIS; ELECTRIC POTENTIAL; ELECTROSPRAY MASS SPECTROMETRY; IONIZATION; MASS SPECTROMETRY; NARCOLEPSY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; QUALITY CONTROL; REACTION ANALYSIS; REVERSED PHASE LIQUID CHROMATOGRAPHY; STRUCTURE ANALYSIS;

BENZHYDRYL COMPOUNDS; CENTRAL NERVOUS SYSTEM STIMULANTS; CHROMATOGRAPHY, LIQUID; HYDROXAMIC ACIDS; MOLECULAR STRUCTURE; REPRODUCIBILITY OF RESULTS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TANDEM MASS SPECTROMETRY;

EID: 67649945671     PISSN: 16159306     EISSN: 16159314     Source Type: Journal    
DOI: 10.1002/jssc.200800647     Document Type: Article

References (20)

1. Boyd, B., Castaner, J., Drugs Future 2006, 31, 17-21.
2. Roth, T., Czeisler, C. A., Walsh, J. K., Wesnes, K. A. et al., Neuropsychopharmacology 2005, 30, S140.
3. Robertson, P., Jr., Hellriegel, E. T., Clin. Pharmacokinet. 2003, 42, 123-137.
4. Castaner, J., Drugs Future 1990, 15, 130-132.
5. Studzinski, C. M., Araujo, J. A., Milgram, N. W., Prog. Neuropsychopharmacol. Biol. Psychiatry 2005, 29, 489-498.
6. Siwak, C. T., Tapp, P. D., Milgram, N. W., Pharmacol. Biochem. Behav. 2003, 76, 161-168.
7. Siwak, C. T., Callahan, H., Milgram, N. W., Prog. Neuropsychopharmacol. Biol. Psychiatry 2000, 24, 709-726.
8. Gorman, S. H., J. Chromatogr. B 2002, 767, 269-276.
9. Schwertner, H. A., Kong, S. B., J. Pharm. Biomed. Anal. 2005, 37, 475-479.
10. McKinney, A. R., Suann, C. J., Stenhouse, A. M., Rapid Commun. Mass Spectrom. 2005, 19, 1217-1220.
11. Burnat, P., Robles, F., Do, B., J. Chromatogr. B 1998, 706, 295-304.
12. Cass, Q. B., Kohn, C. K., Calafatti, S. A., Aboul-Enein, H. Y., J. Pharm. Biomed. Anal. 2001, 26, 123-130.
13. Drouin, J. E., Broquaire, M., J. Chromatogr. 1992, 605, 19-31.
14. Tseng, Y., Uralets, V., Lin, C. T., Kuo, F. H., J. Pharm. Biomed. Anal. 2005, 39, 1042-1045.
15. Becue, T., J. Chromatogr. 1991, 557, 489-494.
16. ICH Steering Committee, ICH International conference on harmonization of technical requirements for registration of Pharmaceuticals for Human use, Impurities in New Drug Products, Geneva, Switzerland, 6 February 2002, Q3A (R1).
17. ICH Steering Committee, ICH International conference on harmonization of technical requirements for registration of Pharmaceuticals for Human use, Impurities in New Drug Products, Geneva, Switzerland, 6 February 2002, Q3B (R1).
18. Prisinzano, T., Podobinski, J., Tidgewell, K., Luo, M., Swenson, D., Tetrahedron Asymmetry 2004, 15, 1053-1058.
19. Chatterjie, N., Stables, J. P., Wang, H., Alexander, G. J., Neurochem. Res. 2004, 29, 1481-1486.
20. Rao, R. N., Shinde, D. D., Talluri, M. V. N. K., Talanta 2007, 73, 407-414.